Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor

Transfusion

Volumn 38, Issue 3, 1998, Pages 307-311

  De Filippi, F ^a   Castelli, R ^a   Cicardi, M ^a   Soffredini, R ^a   Rumi, M G ^a   Silini, E ^b   Mannucci, P M ^c   Colombo, M ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; COMPLEMENT COMPONENT C1S INHIBITOR; HEPATITIS ANTIBODY; HEPATITIS C ANTIBODY;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ANGIONEUROTIC EDEMA; ARTICLE; FEMALE; HEPATITIS C VIRUS; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA TRANSFUSION; POLYMERASE CHAIN REACTION; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0031917327     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1998.38398222877.x     Document Type: Article

References (20)

1. Fletcher ML, Trowell JM, Craske J, et al. Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J (Clin Res Ed) 1983;287:1754-7.
2. Makris M, Preston FE, Triger DR, et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990;335:1117-9.
3. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
4. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;6:564-9.
5. Tacke M, Kiyosawa K, Stark K, et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997;349:318-20.
6. Masuko K, Mitsui T, Iwano K, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996;334:1485-90.
7. Wang JT, Tsai FC, Lee CZ, et al. A prospective study of transfusion-transmitted GB virus C infection: similar frequency but different clinical presentation compared with hepatitis C virus. Blood 1996;88:1881-6.
8. Jarvis LM, Davidson F, Hanley JP, et al. Infection with hepatitis G virus among recipients of plasma products. Lancet 1996;348:1352-5.
9. Nakatsuji Y, Shih JW, Tanaka E, et al. Prevalence and disease association of hepatitis G virus infection in Japan. J Viral Hepat 1996;3:307-16.
10. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131-2.
11. Alter H, Nakatsuji Y, Melpolder J, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;336:747-54.
12. Krawczynski K, Gallagher M, Spelbring J, et al. Experimental HGV infection in primates (abstract). In: Ninth Triennial International Symposium on Viral Hepatitis and Liver Disease, Rome, Italy, April 21-25, 1996:39.
13. Waytes AT, Rosen FS, Frank MM. Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 1996:334:1630-4.
14. Cicardi M, Mannucci PM, Castelli R, et al. Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate. Transfusion 1995;35:209-12.
15. Lampertico P, Rumi MG, Romeo R, et al. A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion associated hepatitis C. Hepatology 1994;19:19-22.
16. Kwok S, Higuchi R. Avoiding false positive with PCR. Nature 1989;339:237-8 [erratum: Nature 1989;339:490].
17. Pocock SJ. Clinical trials. A practical approach. New York: Wiley and Sons 1984.
18. De Filippi F, Colombo M, Rumi MG, et al. High rates of hepatitis G virus infection in multitransfused hemophilic patients. Blood 1997;90:4634-7.
19. Hadziyannis S, Wages J, Kim JP, et al. Frequency of viremia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products (abstract). J Hepatol 1995;23(Suppl 1):78.
20. Mannucci PM. The choice of plasma-derived clotting factor concentrates. Balliere's Clin Haemat 1996;9:273.